Prodrugs of purine and pyrimidine analogues for the intestinal di/tri-peptide transporter PepT1: affinity for hPepT1 in Caco-2 cells, drug release in aqueous media and in vitro metabolism
- 1 January 2003
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 86 (2-3) , 279-292
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell lineJournal of Controlled Release, 2001
- Stability and in vitro metabolism of dipeptide model prodrugs with affinity for the oligopeptide transporterEuropean Journal of Pharmaceutical Sciences, 2000
- Stability, metabolism and transport of d-Asp(OBzl)–Ala — a model prodrug with affinity for the oligopeptide transporterEuropean Journal of Pharmaceutical Sciences, 1999
- Cellular Uptake Mechanism of Amino Acid Ester Prodrugs in Caco-2/hPEPT1 Cells Overexpressing a Human Peptide TransporterPharmaceutical Research, 1998
- Valacyclovir: A Substrate for the Intestinal and Renal Peptide Transporters PEPT1 and PEPT2Biochemical and Biophysical Research Communications, 1998
- Influence of oligopeptide transporter binding affinity upon uptake and transport of d-Asp(OBzl)-Ala and Asp(OBzl)-Sar in filter-grown Caco-2 monolayersInternational Journal of Pharmaceutics, 1997
- Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humansAntimicrobial Agents and Chemotherapy, 1995
- Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single-and multiple-dose administration to normal volunteersClinical Pharmacology & Therapeutics, 1993
- Amino Acid Ester Prodrugs of AcyclovirAntiviral Chemistry and Chemotherapy, 1992
- Pharmacokinetics of acyclovir after intravenous and oral administrationJournal of Antimicrobial Chemotherapy, 1983